Skip to main content

US DoD Awards Invitrogen Subsidiary $970K to Develop Protein Arrays for Biothreat Agents

NEW YORK, Jan. 10 (GenomeWeb News) - Invitrogen said today that the US Department of Defense has awarded its Federal Systems subsidiary $970,000 to develop protein microarrays for biothreat agents.

 

The work is designed to support the US Army Medical Research and Material Command, Invitrogen said. The research will be conducted under the direction of James Meegan, senior director of research and development at Invitrogen; and Robert Ulrich of the US Army Medical Research Institute of Infectious Diseases.

 

Invitrogen's ProtoArray protein microarrays consist of complete sets of pure, functional proteins from specific organisms spotted onto glass slides in a high density configuration. Invitrogen developed them in 2001 as a means to enhance the detection and analysis of biomolecular interactions. They are sold using protein sets derived from both the yeast and human genomes.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.